Simos Kedikoglou is a board member at ReDy and has been involved in various executive managerial roles in the Hobart Group since 2012. Prior to joining the Hobart Group, he served as Vice President of Business Development for Boston Scientific, with responsibility for acquisitions, licensing and distribution deals in the US, Europe and Asia. He was formerly an Associate Partner with McKinsey & Company in the US.

Simos Kedikoglou is a board member at ReDy and since 2013 has been CEO of Impulse Dynamics, where he also serves on the Board of Directors. He was previously CEO of MedInvest, a medical technology incubator overseeing 10 portfolio companies, with responsibility for clinical and commercial strategy, technology development and debt and equity financing. He has also served as Corporate Vice President of Business Development for Boston Scientific, responsible for acquisitions, licensing and distribution deals in the US, Europe and Asia, and was Associate Partner with McKinsey & Company in the US, advising clients on acquisitions in pharmaceuticals and medical devices. Simos holds a medical degree from the University of Athens, an MBA with distinction from Harvard Business School, and a Master’s in Public Health from Harvard University. He is a CFA charterholder.